trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Fluoxetine capsules are a selective serotonin reuptake inhibitor indicated for the acute and maintenance treatment of Major Depressive Disorder.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
4 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that Fluoxetine capsules are a selective serotonin reuptake inhibitor indicated for the acute and maintenance treatment of Major Depressive Disorder?

Yes. Fluoxetine is a well-established selective serotonin reuptake inhibitor (SSRI) used in the management of Major Depressive Disorder.

Verdict: SUPPORTED · 4 sources for, 0 against · Last checked

The analysis

The retrieved literature consistently characterizes fluoxetine as a selective serotonin reuptake inhibitor used in the context of major depressive disorder, aligning with the established pharmacological definition and clinical indications.

Evidence for · 4
2026
Get citation
MG, M. & B, S. (2026). Evidence-Based Pharmacotherapies for Major Depressive Disorder: A Clinical Update.. doi.org. https://doi.org/10.64719/pb.18522

See more details
More for · 3
2026
Get citation
C, G., W, Z., X, X., Q, L., & Y, L. (2026). Comparative efficacy of antidepressants for acute adolescent major depressive disorder: a source-verified systematic review and network meta-analysis.. doi.org. https://doi.org/10.3389/fpsyt.2026.1881200

2026
Get citation
Y, L., J, L., W, L., Y, G., L, N., C, Z., & Q, X. (2026). Celecoxib Ameliorates Chronic Restraint Stress-Induced Depression-Like Behavior in Sprague-Dawley Rats.. doi.org. https://doi.org/10.2147/ndt.s616612

2026
Get citation
J, Y., S, P., K, P., C, K., M, M., M, S., & SJ, R. (2026). Effects of antidepressant administration on physical performance and perceived exertion in athletes: systematic review and meta-analysis.. doi.org. https://doi.org/10.1007/s11096-026-02206-z

What does the evidence say?

The retrieved literature consistently characterizes fluoxetine as a selective serotonin reuptake inhibitor used in the context of major depressive disorder, aligning with the established pharmacological definition and clinical indications.

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work